Pretoria, 28 September 2025 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reassure the public that paracetamol remains a safe and recommended option for the relief of pain and fever during pregnancy, when used short-term at recommended doses. Paracetamol is one of the...
Pretoria, 21 August 2025 – The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has obtained a clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2024/2025 financial year, following its first clean audit for the 2023/24...
Pretoria, 02 July 2025 – The South African Health Products Regulatory Authority (SAHPRA) welcomes its newly appointed Board Members. The SAHPRA Board is appointed by the Minister of the National Department of Health, Dr Aaron Motsoaledi. The appointment is in accordance with section 2C(2) of...
Cape Town - The Radiation Control (RadCon) Unit of the South African Health Products Regulatory Authority (SAHPRA) attended a Search and Secure training held by the Office of Radiological Security (ORS) within the USA’s Department of Energy during 19 – 23 May 2025 in Cape...
A Thought Leadership Article by SAHPRA's CEO, Dr Boitumelo Semete-Makokotlela Introduction Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems, which play a crucial role in ensuring public safety. The South African Health Products...
04 June 2025 - The South African Health Products Regulatory Authority (SAHPRA) recently visited the Egyptian Drug Authority (EDA) at their Cairo Offices for an intensive training programme to capacitate the Regulator on how to achieve recognition for the World Health Organization (WHO) Global Benchmarking...
Pretoria, 22 May 2025 –The South African Health Products Regulatory Authority (SAHPRA), having applied Reliance on the World Health Organization (WHO) PQ assessment under Emergency Use Listing, has listed the first mpox (monkeypox) in vitro diagnostic (IVD). This serves as an important step in improving global access to mpox testing by using a reliance process. The emergency use approval of the Alinity m MPX...
Pretoria, 24 March 2025 –The South African Health Products Regulatory Authority (SAHPRA), in partnership with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of the Witwatersrand, proudly announces the graduation of the fourth cohort from the Clinical Assessors Short Course —...
The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Ref: SAHPRA20862023 - The EOI was closed on Friday, 15 December 2023. VET - Two (2) external evaluators for the...
Cairo, Egypt, 4 February 2025: The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) are proud to announce the signing of a Memorandum of Understanding (MoU) among Africa’s WHO Maturity Level 3...
